In the most recent trading session, Diebold Nixdorf, Incorporated (DBD) closed at $63.49, indicating a -2.19% shift from the previous trading day.
Diebold Nixdorf is emerging from a period of operational restructuring, evidenced by a 25.7% gross margin in Q2 2026 and a 120 basis point improvement in operating margin year-over-year, yet revenue growth remains tepid at 1.7% YoY. The company has reduced tot...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 29, 2026 | $1.10+0.0% vs $1.10 | $928M+0.5% vs $923M |
Q2 2026 Apr 30, 2026 | $0.67+9.8% vs $0.61 | $888M+5.0% vs $846M |
Q1 2026 Feb 12, 2026 | $3.02+87.6% vs $1.61 | $1.1B-0.9% vs $1.1B |
Q4 2025 Nov 5, 2025 | $1.39+110.6% vs $0.66 | $945M-15.2% vs $1.1B |
In the most recent trading session, Diebold Nixdorf, Incorporated (DBD) closed at $63.49, indicating a -2.19% shift from the previous trading day.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
In the latest trading session, Diebold Nixdorf, Incorporated (DBD) closed at $64.91, marking a +1.07% move from the previous day.
The latest trading day saw Diebold Nixdorf, Incorporated (DBD) settling at $65.27, representing a -1.82% change from its previous close.
Benchmark DBD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Diebold Nixdorf, Incorporated (DBD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $63.04 | $2.14B | 24.82 | 1.46% | 2.49% | 9.26% | — | |
| $45.77 | $3.38B | 21.39 | 0.86% | 4.44% | 49.22% | — | |
| $10.24 | $1.64B | 18.96 | 5.79% | 16.05% | 11.17% | — | |
| $34.67 | $17.92B | 46.23 | 5.43% | 27.15% | 22.56% | — | |
| $45.95 | $24.5B | 7.25 | 3.6% | 13.42% | 10.76% | — | |
| $559.92 | $494.73B | 33.89 | 16.53% | 46.34% | 232.28% | — |
Diebold Nixdorf, Incorporated (DBD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Diebold Nixdorf, Incorporated (DBD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 29, 2026·SEC
May 26, 2026·SEC
Apr 30, 2026·SEC
Get notified when DBD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Diebold Nixdorf, Incorporated (DBD) stock FAQ — growth, dividends, profitability & financials explained
Diebold Nixdorf, Incorporated (DBD) reported $3.87B in revenue for fiscal year 2025. This represents a 276% increase from $1.03B in 1996.
Diebold Nixdorf, Incorporated (DBD) grew revenue by 1.5% over the past year. Growth has been modest.
Yes, Diebold Nixdorf, Incorporated (DBD) is profitable, generating $111.2M in net income for fiscal year 2025 (2.5% net margin).
Diebold Nixdorf, Incorporated (DBD) has a return on equity (ROE) of 9.3%. This is below average, suggesting room for improvement.
Diebold Nixdorf, Incorporated (DBD) generated $224.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.